Medivitals was established in January 2020 with a vision to progress the development of a bio-marker monitoring and AI based clinical decision support platform with high sensitivity and specificity for early detection of diseases. Drawing on a strong background in digital health, telemedicine and health informatics, the company has moved into the early stages of development with a focus on using the latest technology to innovate the future of Virtual Healthcare. The Medivitals solution will focus on significant opportunities in hospitals, emergency clinics, aged care facilities, remote and rural areas, mining sites and quarantine hotels/homes.